Skip to main content
Premium Trial:

Request an Annual Quote

Thermo, Fisher Shareholders Approve Merger; Regulatory OK Still Sought

NEW YORK (GenomeWeb News) – Thermo Electron and Fisher Scientific International today said that their shareholders have approved their merger.
 
The companies said that the deal, the largest ever in the biotech industry, remains subject to regulatory approval.
 
As GenomeWeb News reported this week, Fisher said it would divest an undisclosed product line to satisfy the Federal Trade Commission.  The line is worth $17 million, Fisher said.
 
As originally expected, the $10.6 billion deal is scheduled to close by the end of the fourth quarter. The firms announced the deal in May.
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more